EUVIMEDEUVIMED entdecken
Crossref

In Silico and in Vitro Biological Evaluation of Novel Serial Sulfonate Derivatives on Pancreatic Lipase Activity

Fuat Yetişsin, Adem Korkmaz iD, Esin Kaya

Chemistry & Biodiversity · 2023-11 · 20 (11)

DOI: 10.1002/cbdv.202301210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 16.10.2023. Verfasst von Fuat Yetişsin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Muş Alparslan University, Technical Sciences Vocational School, 49250, Muş, Turkey. Hauptthemen laut MEDLINE: Lipase, Benzothiazoles. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Alparslan University, Erciyes University Technology Research and Application Center, Eastern Anatolia High Technology Application and Research Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The novel benzothiazole sulfonate hybrid derivatives containing azomethine group were synthesized and characterized using 1 H‐NMR, 13 C‐NMR, and HR‐MS analysis. The potential enzyme inhibition activities against pancreatic lipase of the novel benzothiazole sulfonate hybrid derivatives containing azomethine group were screened with in vitro and in silico methods. IC 50 values of compounds 5 b (23.89 μM), 5 i (28.87 μM), and 5 f (30.13±4.32) were found to be more effective pancreatic lipase inhibitors than orlistat (57.75 μM) in vitro studies. Also, the binding affinities of compounds 5 b (−8.7 kcal/mol), 5 i (−8.6 kcal/mol), and 5 f (−8.9 kcal/mol) were found potential inhibitors for pancreatic lipase in silico studies. In addition, the absorption distribution, metabolism, and excretion properties (ADME), molecular properties, toxicity estimation, and bioactivity scores of the synthesized compounds were scanned. It was found to have the ability to cross the brain‐blood barrier for compounds 5 a , 5 b , 5 c , and 5 d . All compounds were calculated to be taken orally as drugs, suitable for absorption in the intestinal tract and not carcinogenic, as well as very strongly bound to plasma proteins. Finally, compound 5 f was observed to be the best inhibitor for pancreatic lipase according to in vitro and in silico studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipaseBenzothiazolesMolecular StructureStructure-Activity RelationshipMolecular Docking SimulationAzo CompoundsThiosemicarbazones

Stichwörter der Autor:innen

ADMETbenzothiazolemolecular dockingpancreatic lipasesulfonate derivatives

Substanzen

LipaseBenzothiazolesazomethineAzo CompoundsThiosemicarbazones

Autor:innen und Institutionen

  • Muş Alparslan University, Technical Sciences Vocational School, 49250, Muş, Turkey.
  • Faculty of Health Sciences, Muş Alparslan University, 49250, Muş, Turkey.
  • Faculty of Education, Muş Alparslan University, Muş, 49250, Turkey.

ORCID-Profile: Adem Korkmaz

Förderung

  • Alparslan University
  • Erciyes University Technology Research and Application Center
  • Eastern Anatolia High Technology Application and Research Center

Zitieren

APA

Yetişsin, F., Korkmaz, A., & Kaya, E. (2023). In Silico and in Vitro Biological Evaluation of Novel Serial Sulfonate Derivatives on Pancreatic Lipase Activity. Chemistry & Biodiversity, 20(11). https://doi.org/10.1002/cbdv.202301210

Vancouver

Yetişsin F, Korkmaz A, Kaya E. In Silico and in Vitro Biological Evaluation of Novel Serial Sulfonate Derivatives on Pancreatic Lipase Activity. Chemistry & Biodiversity. 2023;20(11). doi:10.1002/cbdv.202301210

BibTeX
@article{Yetisin2023,
  author = {Yetişsin, Fuat and Korkmaz, Adem and Kaya, Esin},
  title = {In Silico and in Vitro Biological Evaluation of Novel Serial Sulfonate Derivatives on Pancreatic Lipase Activity},
  journal = {Chemistry & Biodiversity},
  year = {2023},
  volume = {20},
  number = {11},
  doi = {10.1002/cbdv.202301210}
}
Kostenlos starten →